Letter to the Editor
B-cell epitopes from the cancer testis antigen NY-ESO-1
Klaus-Dieter Preuss,
Klaus-Dieter Preuss
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Evi Regitz,
Evi Regitz
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Frank Neumann,
Frank Neumann
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Michael Pfreundschuh,
Corresponding Author
Michael Pfreundschuh
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Fax: +496841-1623101.
Medizinische Klinik I, Saarland University Medical School, Kirrberger Strasse, D-66421 Homburg (Saar), Germany
Search for more papers by this author
Klaus-Dieter Preuss,
Klaus-Dieter Preuss
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Evi Regitz,
Evi Regitz
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Frank Neumann,
Frank Neumann
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Search for more papers by this author Michael Pfreundschuh,
Corresponding Author
Michael Pfreundschuh
Medizinische Klinik I, Saarland University Medical School, Homburg, Germany
Fax: +496841-1623101.
Medizinische Klinik I, Saarland University Medical School, Kirrberger Strasse, D-66421 Homburg (Saar), Germany
Search for more papers by this author
First published: 26 October 2005
No abstract is available for this article.
References
- 1
Zeng G,
Aldridge ME,
Wang Y,
Pantuck AJ,
Wang AY,
Liu YX,
Han Y,
Yuan YH,
Robbins PF,
Dubinett SM,
deKernion JB,
Belldegrun AS.
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.
Int J Cancer
2005;
114:
268–73.
- 2
Neumann F,
Wagner C,
Kubuschok B,
Stevanovic S,
Rammensee HG,
Pfreundschuh M.
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.
Cancer Immunol Immunother
2004;
53:
589–99.
- 3
Held G,
Matsuo M,
Epel M,
Gnjatic S,
Ritter G,
Lee SY,
Tai TY,
Cohen CJ,
Old LJ,
Pfreundschuh M,
Reiter Y,
Hoogenboom HR,
Renner C.
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
Eur J Immunol
2004;
34:
2919–29.
